Scarica l'app Stockscreener
10.92
0.46%
-0.05
Dopo l'orario di chiusura:
10.89
-0.03
-0.27%
Benitec Biopharma Inc Azioni (BNTC) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
36.46%
13.38
|
9.803 | 9.834 | 10.19 | 8.61 |
| Operating Income/Loss |
36.46%
-13.38
|
-9.803 | -9.834 | -10.19 | -8.61 |
| Nonoperating Income/Loss |
83.77%
1.54
|
0.838 | 1.029 | 0.834 | 1.253 |
| Income/Loss From Continuing Operations Before Tax |
32.04%
-11.84
|
-8.965 | -8.805 | -9.354 | -7.357 |
| Income/Loss From Continuing Operations After Tax |
32.04%
-11.84
|
-8.965 | -8.805 | -9.354 | -7.357 |
|
Net Income/Loss
|
32.04%
-11.84
|
-8.965 | -8.805 | -9.354 | -7.357 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
10.72%
45.97
|
41.52 | 41.16 | 38.60 | 22.08 |
| Diluted Average Shares |
10.72%
45.97
|
41.52 | 41.16 | 38.60 | 22.08 |
| Basic Earnings Per Share |
18.18%
-0.26
|
-0.22 | -0.21 | -0.24 | -0.33 |
| Diluted Earnings Per Share |
18.18%
-0.26
|
-0.22 | -0.21 | -0.24 | -0.33 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):